Genetic approaches such as retrovirus-mediated mutagenesis and cDNA expression libraries have contributed greatly to our understanding of signal transduction in mammalian cells. However, previously described methods for retroviral insertional mutagenesis are hindered by low mutagenesis rates and diculties in cloning mutated genes. cDNA expression library methods are usually celltype dependent and bias towards abundant and short messages. With the near completion of the genome projects, alternative genetic methods are needed where large numbers of genes can be more easily isolated and biochemically studied. We have developed a novel retrovirus-mediated genetic screening method in cultured cells. To achieve ecient and regulated mutagenesis, we constructed Enhanced Retroviral Mutagen (ERM) vectors that contained several engineered sequences (e.g., an ERM Tag and a splice donor) controlled by a tetracycline-responsive promoter. Endogenous genes can thus be randomly activated and tagged in a conditional system. NIH3T3 cells were used to screen for focusforming genes using the ERM strategy. We showed that these added sequences increased the screening eciency by 410-fold, and allowed more direct identi®cation of the genes targeted. Sequence analysis of *10% of the 4600 focus clones recovered revealed both known oncogenes and novel factors such as protein kinases and GTP/GDP exchange proteins. The ERM strategy should help to facilitate large-scale gene identi®cation in diverse pathways and integrate both genetic (with the completion of the genome projects) and functional information more readily. Oncogene (2000) 19, 5964 ± 5972.
Introduction
An essential step in studying signal transduction is the understanding of its regulatory genes. Classic genetic screen approaches that utilize transposons and chemical mutagens to generate loss-of-function mutants have proven successful in identifying many central players of signal pathways, particularly in yeast, C. elegans, and Drosophila (Simon et al., 1992; Kuwabara, 1997) . Gain-of-function screens using transposons (to insert enhancer sequences) have also been reported in Drosophila (Rorth, 1996; Rorth et al., 1998) . Several approaches have been developed for mammalian genetic studies. Homologous recombination (Mansour et al., 1988; Capecchi, 1989; Dorin et al., 1989; Johnson et al., 1989; Thompson et al., 1989) , retroviral gene trapping (Gossler et al., 1989; von Melchner and Ruley, 1989; Friedrich and Soriano, 1991; Brennan and Skarnes, 1999) , generation of transgenic animals (Jaenisch, 1988) , and random gene activation/inactivation by wildtype retroviruses are among the widelyused methods (Hayward et al., 1981; Mushinski et al., 1983; Robinson et al., 1983; Jaenisch and Soriano, 1986; Tsichlis, 1987; Berns, 1988; Kung et al., 1991; Sorensen et al., 1996; Li et al., 1999) . These studies often utilize whole animals or embryonic stem (ES) cells and have advanced tremendously our knowledge in signal transduction. Mammalian signal pathways can be studied genetically in tissue culture cells as well. Cultured cells can grow to large numbers within a short time and techniques for gene transfer into cultured cells have been well established. One approach involves constructing expression cDNA libraries and isolating candidate genes based on phenotypic changes in the cells (D'Andrea et al., 1990; Wong et al., 1994; Whitehead et al., 1995a; Kojima and Kitamura, 1999) .
Insertional activation by wildtype retroviruses and cDNA expression libraries are two well-established gain-of-function methods in mammalian cells. One potential limitation is that random gene activation by wildtype retroviruses may be of low frequency and the aected genes dicult to locate. The success of the expression cDNA library technique often depends on the quality and source of the cDNA libraries. Dierent sets of genes may be transcribed in dierent cell types, and cDNA expression libraries may bias towards shorter cDNAs. In addition, expression of the cDNA is often controlled by a constitutively active exogenous promoter such as a retroviral LTR, making it dicult to distinguish targeted mutants from spontaneous mutants.
We have developed a retrovirus-mediated genetic screen which can be used to study signaling pathways throughout the genome. This approach is analogous to gain-of-function transposon mutagenesis in Drosophila (Rorth, 1996; Rorth et al., 1998) . Retroviruses are believed to integrate randomly in the genome which may result in insertional mutagenesis. Compared to traditional retrovirus-mediated insertional mutagenesis which also takes advantage of these properties of the retroviruses, our murine retroviral vector constructs (named Enhanced Retroviral Mutagen or ERM) contained several engineered sequences. These sequences make it possible to achieve ecient and regulated mutagenesis. To validate the ERM strategy, NIH3T3 cells were used to screen for focus-forming loci. We showed that the sequences engineered into the ERM vectors not only signi®cantly increased the screening eciency (410-fold), but also allowed more direct cloning and identi®cation of the gene loci targeted. Sequence analysis of 54 of the 4600 isolated focus clones revealed both known oncogenes and novel factors. Our results demonstrate that the ERM approach can be a powerful tool for large-scale gene identi®cation in diverse pathways and help to facilitate the integration of genetic and functional information.
Results

Design of the ERM vectors
Previously described genetic screens that used retrovirus-mediated insertional activation mutagenesis relied largely on the ability of the retroviral LTRs to activate endogenous genes (Robinson et al., 1983; Tsichlis, 1987; Li et al., 1999) . Because the LTR promoter is relatively weak and the 3' LTR promoter is often suppressed (Brown and Robinson, 1988; Guntaka, 1993) , the eciency of insertional activation is generally very low. If the virus integrates many kilobases away from an exon, identi®cation of thè targeted' gene, which usually involves inverted PCR, may become dicult. In addition, insertional mutagenesis by conventional retroviral vectors are usually irreversible. This lack of regulated mutagenesis can be problematic in cases where terminal dierentiation or high background spontaneous mutations need to be avoided.
To circumvent these problems, ERM vectors were constructed that contained several added features collectively called the ERM cassette. This cassette was cloned into the U3 region of the 3' LTR of a retroviral vector (pBabe) (Figure 1a ). Within the ERM cassette were sequences for expression of a mutagenesis tag (ERM Tag), and a consensus splice donor sequence (AAGGTAAGT) under the control of a promoter that could be turned o by tetracycline (tet-o) (Gossen et al., 1993; Paulus et al., 1996) . Within the ERM Tag region, dierent structural or targeting motif sequences (e.g., myristylation signal) can be included upstream of an AU1 peptide epitope. Three sets of vectors corresponding to the three reading frames of the ERM Tag were generated in order to target endogenous genes in all possible reading frames. The inclusion of the splice donor sequences should allow splicing and subsequent fusion of the 5' ERM Tag sequences to the endogenous exons near the integration site. When a fusion transcript is generated, direct cloning of the retrovirally targeted genes can be more easily achieved by RT ± PCR and 3' RACE ( Figure 1b) . Importantly, the tetracycline-regulated promoter of the ERM vectors should prove immensely useful during genetic screens. The tet-o system would allow one to distinguish authentic integration events from spontaneous mutants. Integration of the ERM retrovirus may result in mutagenesis of the endogenous genes in several ways (Figure 1b) . A fusion transcript that contains the ERM Tag sequences may be generated from the ERM tetracycline-regulated promoter. Alternatively, ERM integration may upregulate transcription of a nearby gene locus through its endogenous promoter, due to the presence of the exogenous ERM enhancer elements (Figure 1b) . Either expression of the resulting fusion molecules or enhanced expression of the endogenous gene may be sucient for phenotypic changes.
Our ERM strategy signi®cantly improves upon traditional retroviral insertional mutagenesis approaches because of the employment of the mutagenesis tag and the regulated promoter. The ERM strategy also enables ecient genetic screens in mammalian cells without the need of constructing cDNA libraries. In principle, retroviral insertion can lead to either activation or inactivation of an endogenous gene allele depending on where the viral DNA is integrated. However, loss of function of a single allele is less likely to result in a mutant phenotype in somatic cells. Therefore, ERM-mediated mutagenesis is expected to be primarily a gain-of-function screen.
The ERM Tag allows efficient mutagenesis Dierent types of ERM Tag can be engineered into the ERM vectors. We ®rst tested the ERM Tag that encoded a chicken c-Src myristylation signal upstream of an AU1 epitope. It has been found that most signal proteins need to be targeted to signal complexes at the membrane for normal function (Pawson and Scott, 1997) . Such targeting is usually mediated by protein modules (e.g., SH2, PTB, SH3 and PH domains) or speci®c sequences (e.g., myristylation, farnesylation and palmitoylation signals). In addition, many transforming retroviral oncogene products (e.g., v-Abl, vAkt, v-Fgr, v-Fes, v-Ras and v-Raf) are targeted to the membrane through the myristylation signal present in the viral Gag sequences (Barbacid and Aaronson, 1978; Barbacid, 1981; Srinivasan et al., 1981; Gonda et al., 1982; Rapp et al., 1983; Naharro et al., 1984; Schultz and Oroszlan, 1984; Buss et al., 1989; Ahmed et al., 1993) . Therefore, tagging cellular gene products with an exogenous myristylation signal may bypass normal targeting pathways thereby directly activating these proteins.
To evaluate the mutagenesis eciencies of ERM Tag, three constructs were compared: a conventional vector without any ERM Tag sequences (pBabe), a vector encoding the AU1 epitope alone and the arti®cial splice donor (Tet-AU-SD), and the ERM construct that carried the myristylation ERM Tag (TetMyrAU-SD). These constructs were transfected into the retrovirus packaging line BOSC23 (Pear et al., 1993) . The virus titers obtained under these conditions (*5610 5 /ml) were similar to those of conventional vectors. The viral supernatants were used to infect and mutagenize NIH3T3 cells. As shown in Figure 2 , the Tet-AU-SD construct induced slightly more foci (*2 foci/well) compared to the conventional vector (*1 focus/well). Signi®cantly, the Tet-MyrAU-SD ERM virus generated 16 foci/well, a more than 10-fold increase in mutagenesis eciency. These results demonstrate that the engineered ERM Tag containing the myristylation signal enabled the ERM virus to tag and activate cellular genes much more eciently.
To further validate the ERM approach, the TetMyrAU-SD construct was used to screen NIH3T3 cells for genes that might induce oncogenic transformation. NIH3T3 cells were infected with ERM viruses in three possible reading frames (RF1, RF2 and RF3). More than 600 foci were recovered. These foci exhibited Oncogene Enhanced retroviral mutagen-mediated genetic screens D Liu et al distinct morphologies (Figure 2b ), suggesting that dierent classes of genes had been targeted by the ERM viruses.
Molecular cloning and identification of the transforming genes
To investigate which gene loci were mutagenized by ERM, 54 individual focus clones from RF1 and RF2 ERM screens were expanded to extract RNAs. RT ± PCR and 3' RACE were subsequently performed to amplify the fusion transcripts using primers from the 5' unique ERM Tag sequences, and the PCR products were directly sequenced. The sequences obtained were then used to search the Genebank Non-Redundant and Expressed-sequence-tag (EST) databases using the NCBI Blast program. Results from analyses of the 54 clones are tabulated in Table 1 . A total of 46 clones yielded PCR products that exhibited sequence homology to genes in the databases. These 46 sequences encode 13 independent transforming genes ( Table 2) . Based on these frequencies, we estimated that the 600 isolated foci should represent 50 ± 100 dierent transforming genes. These results demonstrate the validity, eectiveness and reliability of the ERM approach. There were eight clones that did not show homology to any sequences in the databases. The identity of the gene loci targeted in these clones may come to light once the sequences of the complete mouse and human genomes become available. Among the 13 independent genes, seven are known mouse genes that include TRAD (Kawai et al., 1999) , Dbs (Whitehead et al., 1995b) , ARL2 (Clark et al., 1993) , A-Raf (Huleihel et al., 1986; Storm et al., 1990) , MEK6 (Cuenda et al., 1996; Stein et al., 1996) , CD30 (Chiarle et al., 1999) and PCD Cdr2 (Darnell, 1996) . All these genes have been implicated in cell growth regulation. While A-Raf and MEK6 modulate activities of MAP kinases (Khosravi-Far and Der, 1994; Su and Karin, 1996) , Ras-like small GTPase ARL and dbl family guanine nucleotide exchanger factors TRAD and Dbs haven been shown to regulate cytoskeleton, gene expression and induce cellular transformation (Norman et al., 1998; Whitehead et al., 1999) . CD30, originally identi®ed as a cell surface marker for Hodgkin's lymphoma cells, is a member of the tumor necrosis factor receptor family (Chiarle et al., 1999) . PCD Cdr2 directly binds to c-Myc and may therefore regulate cell growth (Okano et al., 1999) . It is also the major auto-antigen that causes paraneoplastic cerebellar degeneration in breast cancer and ovarian cancer patients (Darnell, 1996) .
The screen also identi®ed six novel genes ( Table 2) . Three of them are novel ESTs with no apparent sequence homology to known genes or sequences. Of the remaining three, one encodes a novel protein with a serine-protease homology domain and was therefore named OSP-1 for Oncogenic Serine Protease-1. The other two show sequence homology to dbl family quanine nucleotide exchanger factors (GEFs) and were named GEF-T and GEF-K respectively. GEF-T is most homologous to human Trio (49% identical) and GEF-K to the human KIAA0521 protein (70% identical).
To con®rm the ability of CD30, OSP-1, GEF-K and GEF-T to transform NIH3T3 cells, these genes were cloned into retroviral vectors. Infection of NIH3T3 cells with viruses encoding GEF-T, GEF-K and OSP1 strongly induced focus formation within 1 week, while CD30 viruses induced moderate numbers of transformed foci (Table 2 ). These results demonstrate that the ERM strategy can be used to identify both known and novel genes that regulate cell signaling.
ERM Tag fusion products can be expressed
One important advantage of the ERM strategy is that the integrated retroviral mutagens may generate fusion proteins that are tagged with the AU1 epitope. Expression of potential fusion products was examined in 14 RF1 ERM focus clones using an anti-AU1 monoclonal antibody. Most of the clones examined did indeed express fusion proteins ranging in molecular weight from 40 ± 150 kDa (Figure 3a) . The expression levels of these fusion proteins varied, probably re¯ecting their cellular stability. No detectable levels of fusion proteins could be found in a number of clones. The fusion proteins might be unstable even though the fusion transcripts were in-frame with the ERM Tag (Table 1) . Alternatively, transformation of these cells by ERM was a result of increased endogenous gene expression without the generation of fusion proteins (enhancer eect).
ERM-mediated mutagenesis may be regulatable
If the transforming phenotype of the isolated NIH3T3 clones was a result of ERM integration, addition of tetracycline should prevent such transformation because the ERM Tag was controlled by a tetracyclineresponsive promoter (tet-o) (Figure 1a ) (Gossen et al., 1993) . Consistent with this notion, the majority of the isolated foci (480%) responded to tetracycline and regressed. To quantitate such responses, two independent focus clones isolated from RF1 ERM mutagenesis were randomly chosen for further assays. As shown in Figure 3b , addition of tetracycline (2 mg/ml) resulted in a four-fold decrease in the numbers of foci formed from both mutant clones. Furthermore, the sizes of foci formed in the presence of tetracycline were much smaller (data not shown). Importantly, expression of the ERM tagged fusion proteins was greatly reduced in the presence of tetracycline (Figure 3b ). These observations indicate that the retrovirally targeted gene was responsible for the transforming phenotype, and demonstrate that response to tetracycline may be used to distinguish`true' positive mutant cells that have been mutagenized by ERM from spontaneous mutants.
The ERM myristylation signal potentiates gene transformation
One unique feature of ERM vectors is the inclusion of a myristylation signal in the ERM Tag (Figure 1 ). To con®rm that the myristylation signal allows membrane targeting and activation of the fusion protein, the subcellular localization of AU1-tagged A-Raf (targeted in several clones) with (MyrAU-Raf) or without the myristylation signal (AU-Raf) was examined in NIH3T3 cells (Figure 4a ). Nearly 90% of AU-Raf was localized in the cytosol (S100 fraction) and *10% in the membrane (P100 fraction). In contrast, MyrAURaf had *30% localized in the cytosol and *60% in the membrane. The enhancement of membrane targeting by the myristylation signal appeared to be similar to the subcellular localization for myristylated v-Akt vs c-Akt (Ahmed et al., 1993) . To further validate that the ERM myristylation signal would allow more sensitive detection of transforming genes, the transformation eciencies of AU-Raf and MyrAU-Raf were compared. As shown in Figure 4b , NIH3T3 cells expressing MyrAU-Raf exhibited distinct morphological changes compared to those expressing AU-Raf. In addition, MyrAU-Raf was at least 30 times more potent than AU-Raf in focus formation assays (Figure 4c ), supporting our hypothesis that the inclusion of the myristylation signal in ERM Tag facilitates membrane targeting and potentiates gene transformation.
Analysis of ERM virus integration
Consistent with the idea that ERM viruses encoding dierent ERM Tag reading frames could activate dierent sets of genes, the genes isolated using RF1 ERM were mostly distinct from those of RF2 ERM. Both GEF-T and GEF-K were identi®ed from RF1 as The region of the endogenous gene product (known genes) included in the ERM-Tag fusion product. well as RF2 ERM screens. However, the gene products identi®ed were of dierent length in the two reading frame screens (Table 2) , presumably a result of dierent ERM integration events that had targeted dierent exons of the same gene. Sequencing analyses of ERM mutant clones indicated that a number of gene loci had been targeted multiple times. For instance, the GEF-T locus was targeted 14 times (14/54) and the A-Raf locus was targeted ®ve times (5/54). Such frequent targeting may re¯ect high copy numbers of the targeted gene loci since NIH3T3 cells are tetraploid. Alternatively, it may indicate the strength of the targeted genes in inducing transformation (penetrance). To investigate how identical phenotypes may have resulted from dierent ERM integration in the same locus, the integration sites were cloned from two clones (RF1-2 and RF1-8) in which the Raf locus was targeted. As shown in Figure 5 , the ERM viruses integrated at 2.3 and 2.6 kb upstream of the 5' end of Raf exon 2 in clones RF1-2 and RF1-8 respectively.
Discussion
The major signi®cance of the ERM method is the usage of the ERM mutagenesis tag and arti®cial splice donor to facilitate cloning of the targeted genes as well as to tag these genes with dierent N-terminal motif sequences. These`extra' sequences have proven extremely bene®cial for our screening. The addition of a myristylation signal resulted in a 10-fold increase in mutagenesis rate; and we were able to identify the parental NIH3T3 cells in the presence (+Tet) or absence (7Tet) of 2 mg/ml tetracycline. The number of foci formed was determined after 1 week. Whole cell lysates from these two clones maintained in the presence (+) or absence (7) of tetracycline were analysed by Western analysis using an anti-AU1 antibody. An anti-Grab2 antibody was used as loading control. Speci®c ERM fusion protein bands are indicated by *. Ctr indicates control NIH3T3 cell lysate genes targeted in *90% of the clones analysed so far using direct RT ± PCR. It should be noted that our use of the splice donor and ERM Tag diers from previous retroviral gene-trapping vectors. Splice donors have been included in retroviral gene-trapping vectors (Yoshida et al., 1995; Zambrowicz et al., 1998; Wiles et al., 2000) . However, the main purpose of the splice donor in these vectors was to trap the downstream splice acceptor sites and poly-(A) + signals in the endogenous loci through a drug selection marker. Furthermore, unlike the ERM vectors, stop codons were included upstream of the arti®cial splice donor in the previous vectors thereby preventing them from generating fusion proteins. Retroviral-trapping vectors to identify genes that contain speci®c localization signals have been described (Skarnes et al., 1995; Tate et al., 1998; Kojima and Kitamura, 1999) . However, in these gene-trapping approaches, the presence or absence of localization signals in the resulting fusion transcripts depends completely on endogenous gene sequences, because exogenous sequences are fused to the C-termini of the endogenous genes. In addition, expression of the resulting fusion transcripts is controlled by the endogenous promoter and the fusion proteins are therefore less likely to be activated, in contrast to the ERM method in which all fusion products are tagged by the ERM Tag.
Another unique aspect of the ERM approach is the regulated promoter which enables conditional mutagenesis. We have demonstrated that tetracyclineresponsiveness can be used to assay for authentic integration events. This feature should prove especially valuable in genetic screens where there may be a large number of background mutants. Additionally, for screens involving cells that dierentiate during the process, the tetracycline-regulated ERM approach will enable the maintenance of mutant cell populations before they dierentiate and thereby facilitate gene cloning. However, the tet-o system may be`leaky' where the promoter cannot be completely turned o by the presence of tetracycline. We are currently engineering second-generation ERM vectors that contain loxP sites which will allow complete elimination of the ERM Tag.
We were initially concerned that the inclusion of a myristylation signal in the ERM Tag might bias our screens towards signaling molecules located at the membrane. However, results from two genetic screens so far strongly argue against this possibility. Diverse classes of proteins including secreted factors, cytosolic proteins, membrane receptors, and nuclear transcription factors, have been identi®ed using the ERM strategy (Liu et al., 2000) . By immunostaining, we have also found that myristylated proteins can be targeted to dierent cellular compartments such as vesicles and nuclei (data not shown). It should be noted that the ERM Tag is not limited to myristylation signals. Dierent mutagenesis motif sequences may be engineered in the ERM Tag region. For instance, motifs for protein dimerization can be included to identify proteins that require clustering for activation. If a transcription repression domain is included, loss-offunction genetic screens may be performed to search for transcription regulators of various pathways. Such ERM constructs are expected to generate dierent sets of mutants. With these modi®cations, more elaborate genetic screens similar to those performed in lower organisms such as¯ies should become more feasible.
One potential limitation of the ERM method is that intron-less genes may not be tagged by the ERM Tag. However, these genes are much less common. In addition, ERM may up-regulate the expression of full-length endogenous genes, similar to traditional retrovirus insertional mutagenesis vectors (Robinson et al., 1983; Jaenisch and Soriano, 1986; Tsichlis, 1987; Li et al., 1999) . Therefore, ERM should be able to activate intron-less genes as well.
With the completion of the mouse and human genome projects in the near future, one of the major challenges and goals will be to integrate sequence information of dierent genes with biological and functional data. The ERM strategy should be particularly suitable for ful®lling part of this goal. Because of the random nature of retroviral integration (Con, 1990; Zambrowicz et al., 1998) , the ERM vectors in theory have the potential to activate every single gene including those that are normally silent. Essentially, the pool of ERM-infected cells resemble those that have taken up a cDNA library. The dierence lies in the fact that there is no need of constructing a library for every cell type studied or bias towards shorter messages, and that the entire genome may be targeted. Because of its ability to mutagenize genes genome-wide, ERM can be utilized to genetically map on a large scale genes that regulate dierent signaling pathways (e.g., senescence and dierentiation) in either cultured mammalian cells or whole animals. The genes identi®ed from the genome projects can thus be cataloged based on their functions.
Materials and methods
ERM vector design
The ERM vectors are pBabe-puro based (Morgenstern and Land, 1990) . The ERM cassettes containing the tetracyclineresponsive promoter (Gossen et al., 1993) , ERM Tag, and arti®cial splice donor (AAGGTAAGT) were cloned in the Figure 5 The mouse A-Raf locus was independently targeted multiple times by ERM viruses. In clones RF1-2 and RF1-8, fusion transcripts formed when the ERM Tag (hatched box) was spliced into the 5' splice acceptor (SA) site of the A-Raf exon 2. The distance between the integration sites of ERM virus and exon 2 of A-Raf locus is shown. The graph is not drawn to scale. Inverted triangles indicate the ERM integration sites. SD, splice donor. Myr1, Myr1 primer; 1-1, Raf-Exon-1-1 primer; 2-1, RafExon-2-1 primer
NheI site of the 3' LTR. Instead of placing the arti®cial splice donor site in between the LTRs as in previously published retroviral insertional mutagenesis vectors (Yoshida et al., 1995; Zambrowicz et al., 1998) , our design avoids potential complications from the cryptic splice acceptor sequence present in the 3' end of the 5' LTR. The ERM Tag encodes the chicken c-Src myristylation signal (MGSSKSKPKDPSQR) upstream of the AU1 epitope DTYRYI (Tet-MyrAU-SD). The AU1 epitope was chosen because of its small size. A set of three ERM vectors were constructed in which the ERM Tags were in three possible reading frames (RF1, RF2 and RF3).
Cell lines and virus production
NIH3T3 cells were maintained in DMEM media with 10% calf serum (CS). BOSC23 cells were maintained in DMEM media containing 10% fetal calf serum (FCS) (Pear et al., 1993) . The ERM vectors were used to transfect the retroviral packaging cell line BOSC23 as previously described (Pear et al., 1993) . The virus supernatant was then collected, ®ltered through a 0.45 micron syringe ®lter, and used to infect NIH3T3 cells in MOI (multiplicity of infection) of 1 : 1.
NIH3T3 transformation screen and transformation assay
ERM viruses in three possible reading frames that encoded a myristylation signal, the AU1 epitope and a splice donor sequence under the control of a tetracycline-responsive promoter were generated. NIH3T3 cells (*12 million) expressing the transactivator tTA were plated in six-well plates (3610 5 cells per well) and spin-infected with the ERM virus supernatants in the presence of 4 mg/ml polybrene at 2500 r.p.m. for 1 h. The media were changed to 3 ml of 10% CS DMEM the next day. Fresh media were added every 3 days, and the cells were maintained for 2 weeks. Individual focus clones were isolated, selected in puromycin (1 mg/ml), and expanded to extract RNA for further analysis.
To investigate whether genes of interest could induce transformation, candidate genes were subcloned into pBabe retroviral vectors to generate viruses and subsequently infect NIH3T3 cells (1610 5 cells per well). The cells were then maintained in six-well plates and focus formation was determined after 1 week.
RT ± PCR, 3' RACE and PCR primers
Individual fusion transcripts containing the 5' ERM Tag as well as sequences from the endogenous 3' UTR and poly-(A) + sequences can be generated in ERM-infected cells. To identify the gene locus targeted by the virus, individual focus clones were expanded and RNA was extracted using the RNeasy Mini Kit (QIAGEN). Reverse transcription was performed with a random primer RT-1 (5'-GCAAATACGACTCACTATAGG-GATCCNNNN(GC)ACG-3', N=AGCT) using Superscript II (Gibco). The 5' end of RT-1 primer contains sequences for the T7 primer. The cDNA was then PCR ampli®ed with primers from the myristylation signal sequence (Myr1 : 5'-ACCATGG-GGAGCAGCAAGAGCAAACCAAAAGACCCCAGCCA-ACGC-3') and the T7 primer using Taq DNA polymerase (Gibco). The PCR products were then gel puri®ed and directly sequenced.
Tetracycline sensitivity assay
Isolated focus cells were trypsinized and plated in 10% CS DMEM media with or without 2 mg/ml tetracycline for 1 week. The morphology of these cells was examined under a phase-contrast microscope. To quantitate the dierence, approximately 100 ± 1000 cells of interest were plated with 2 ± 5610 5 parental NIH3T3 cells in six-well plates in the presence or absence of 2 mg/ml tetracycline. The numbers of foci formed and the expression of fusion proteins were compared after 1 week.
Western blot
Individual focus clones that have been isolated during the screen were expanded to collect whole cell lysates. The lysates were resolved by SDS ± PAGE, transferred to nitrocellulose membranes, probed with an anti-AU1 monoclonal antibody (Convace), and visualized by ECL.
Subcellular localization
The subcellular localization of Raf expressing cells was examined as described (Ahmed et al., 1993) . Brie¯y, cells were lysed in a hypotonic buer (20 mM HEPES pH 7.5, 1.5 mM MgCl 2 , 10 mM KCl, 1 mM EGTA, 1 mM EDTA and 250 mM sucrose) containing proteinase and phosphatase inhibitors, homogenized with a Dounce homogenizer for 30 strokes. The homogenates were centrifuged at 1000 g for 10 min. The supernatant was then further centrifuged at 100 000 g for 1 h. The pellet (P100) and supernatant (S100) fractions were then examined by SDS ± PAGE and Western blotting using an anti-AU1 antibody.
Genomic PCR for viral integration sites
Genomic DNAs were puri®ed from RF1-2 and RF1-8 clones in which the ERM retroviruses targeted the A-Raf locus. To determine the precise integration sites, PCR reactions were performed using primer pairs Myr1/Raf-Exon-2-1 (5'-CACT-GTGCGTTGCTGTTAGGCAG-3') and Raf-exon-1-1 (5'-TGGTGGTGGTAGGGTGGACAG-3')/Raf-Exon-2-1. The resulting PCR products were gel puri®ed, cloned into the TOPO TA cloning vectors (Invitrogen), and sequenced. A 1.4 kb product was obtained with Raf-exon-1-1 and RafExon-2-1. Using the Myr1/Raf-Exon-2-1 primer pair, a 2.3 kb band was detected in RF1-2 cells and a 2.6 kb band was detected in RF1-8 cells.
